Esperion
is a Michigan-based pharmaceutical company that researches and develops oral therapies for the treatment of cardiovascular and cardiometabolic diseases... Read moreEsperion
is a Michigan-based pharmaceutical company that researches and develops oral therapies for the treatment of cardiovascular and cardiometabolic diseases... Read more
1998
PublicNASDAQESPR
News
Conference Presentation
Mar 24, 2025
Benzinga
Esperion to Participate in 24th Annual Needham Virtual Healthcare Conference
Partnership
Mar 03, 2025
GlobalNewswire
Esperion Partners with CSL Seqirus to Commercialize NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) in Australia
Funding
Dec 13, 2024
Marketscreener
Esperion received $210.1M in Post-IPO Debt Funding
Esperion Competitors
1
2
3
4
5
6
7
8
9
10